|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.52 USD | +9.79% |
|
+12.13% | -5.61% |
| 04-14 | Genscript Biotech Associate Logs $597 Million in Q1 Sales of Carvykti | MT |
| 03-11 | Legend Biotech Shares Likely to Rebound in 2026 on Robust Fundamentals, RBC Says | MT |
| Capitalization | 3.8B 3.21B 2.96B 2.8B 5.21B 354B 5.3B 34.77B 13.61B 170B 14.24B 13.94B 603B | P/E ratio 2026 * |
331x | P/E ratio 2027 * | 18.3x |
|---|---|---|---|---|---|
| Enterprise value | 2.95B 2.5B 2.3B 2.17B 4.05B 275B 4.12B 27.01B 10.57B 132B 11.06B 10.83B 468B | EV / Sales 2026 * |
2.05x | EV / Sales 2027 * | 1.45x |
| Free-Float |
98.8% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Legend Biotech Corporation
| 1 day | +9.79% | ||
| 1 week | +12.13% | ||
| Current month | +13.43% | ||
| 1 month | +9.44% | ||
| 3 months | -7.19% | ||
| 6 months | -39.15% | ||
| Current year | -5.61% |
| 1 week | 17.64 |  | 20.56 |
| 1 month | 16.7 | | 20.56 |
| Current year | 16.24 | | 24.12 |
| 1 year | 16.24 | | 45.3 |
| 3 years | 16.24 | | 77.32 |
| 5 years | 16.24 | | 77.32 |
| 10 years | 16.24 | | 77.32 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ying Huang
CEO | Chief Executive Officer | 53 | 20/09/2020 |
Mythili Koneru
CTO | Chief Tech/Sci/R&D Officer | 48 | 10/04/2023 |
Tracy Luo
CTO | Chief Tech/Sci/R&D Officer | - | 30/04/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Ye Wang
CHM | Chairman | 57 | 05/11/2020 |
Ying Huang
BRD | Director/Board Member | 53 | 29/12/2021 |
Corazon Sanders
BRD | Director/Board Member | 69 | 30/04/2020 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +9.79% | +12.13% | -39.18% | -61.30% | 3.8B | |
| +0.28% | +5.26% | +36.07% | +102.10% | 52.12B | |
| +0.26% | +2.98% | +103.18% | +24.51% | 47.25B | |
| -4.34% | -8.39% | +106.47% | +776.06% | 31.67B | |
| +1.08% | +8.03% | +0.47% | -23.28% | 25.15B | |
| +0.49% | +4.56% | +83.96% | -31.31% | 19.54B | |
| +0.69% | +2.44% | +42.97% | -36.44% | 17.83B | |
| +0.61% | +9.37% | +77.06% | +238.74% | 17.33B | |
| +1.29% | +12.28% | -14.22% | +1,245.22% | 16.38B | |
| -0.10% | +6.86% | +79.41% | - | 15.45B | |
| Average | +0.99% | +5.23% | +47.62% | +248.26% | 24.65B | |
| Weighted average by Cap. | +0.02% | +3.63% | +59.74% | +231.57% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.44B 1.22B 1.12B 1.06B 1.97B 134B 2B 13.15B 5.15B 64.24B 5.39B 5.27B 228B | 1.83B 1.55B 1.43B 1.35B 2.52B 171B 2.56B 16.77B 6.57B 81.94B 6.87B 6.73B 291B |
| Net income | 67.08M 56.82M 52.39M 49.4M 92.15M 6.25B 93.63M 614M 241M 3B 252M 246M 10.66B | 320M 271M 250M 236M 440M 29.84B 447M 2.93B 1.15B 14.33B 1.2B 1.18B 50.87B |
| Net Debt | -847M -717M -662M -624M -1.16B -78.94B -1.18B -7.76B -3.04B -37.9B -3.18B -3.11B -135B | -1.13B -961M -886M -836M -1.56B -106B -1.58B -10.39B -4.07B -50.78B -4.26B -4.17B -180B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/04/26 | 20.52 $ | +9.79% | 2,859,011 |
| 14/04/26 | 18.69 $ | +5.65% | 2,744,699 |
| 13/04/26 | 17.69 $ | -2.59% | 1,763,192 |
| 10/04/26 | 18.16 $ | -0.22% | 2,182,865 |
| 09/04/26 | 18.20 $ | -0.55% | 1,551,266 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- LEGN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition